Other institutional investors and hedge funds have also made adjustments to their positions in MetLife. For instance, Csenge Advisory Group increased its stake by 1.0% in the first quarter, now owning 13,647 shares worth $1,096,000 after acquiring an additional 131 shares. Similarly, Delta Investment Management LLC raised its holdings by 0.9%, bringing its total to 14,265 shares valued at $1,145,000 after acquiring 133 shares. Glenview Trust Co. also increased its stake by 0.4%, now owning 38,333 shares worth $3,078,000 after adding 141 shares. Stock Yards Bank & Trust Co. raised its holdings by 2.5%, owning 6,463 shares valued at $519,000 after acquiring 159 shares. Lastly, My Legacy Advisors LLC increased its stake by 1.2% in the second quarter, now holding 14,000 shares valued at $1,097,000. Notably, institutional investors collectively own 94.99% of the company’s stock.<\/p>\n Recent evaluations from several research firms have been favorable for MetLife. Jefferies Financial Group raised their price target from $100.00 to $103.00, maintaining a \u201cbuy\u201d rating in a report dated August 11th. Cowen reiterated a \u201cbuy\u201d rating on August 22nd, while Wells Fargo & Company issued an \u201coverweight\u201d rating with a target price increase from $94.00 to $97.00 on July 10th. Barclays also boosted their target price from $88.00 to $94.00, giving the stock an \u201coverweight\u201d rating on July 7th. However, Piper Sandler downgraded MetLife from \u201coverweight\u201d to \u201cneutral,\u201d setting a target price of $84.00 on September 19th. Currently, one analyst rates the stock as a Strong Buy, nine as Buy, and two as Hold, resulting in a consensus rating of \u201cModerate Buy\u201d with an average price target of $94.64 according to MarketBeat.com.<\/p>\n View Our Latest Analysis on MET<\/a><\/b><\/p>\n As of Monday, shares of MET stock<\/a> opened at $81.61. The company has experienced a fifty-two week low of $65.21 and a high of $89.05. With a market capitalization of $54.27 billion, MetLife has a price-to-earnings ratio of 13.83, a PEG ratio of 0.74, and a beta of 0.87. The firm\u2019s debt-to-equity ratio stands at 0.57, with both quick and current ratios at 0.16. The stock\u2019s 50-day and 200-day simple moving averages are $78.67 and $78.14, respectively.<\/p>\n MetLife (NYSE:MET<\/a> \u2013 Get Free Report<\/a>) recently reported its quarterly earnings on August 6th, revealing earnings per share of $2.02, which fell short of analysts\u2019 expectations of $2.32 by $0.30. The company recorded a return on equity of 19.88% and a net margin of 5.83%. Revenue for the quarter was $17.34 billion, compared to the anticipated $18.58 billion, marking a 2.7% decrease year-over-year. Analysts forecast that MetLife, Inc. will post earnings per share of 9.65 for the current fiscal year.<\/p>\n Recently, MetLife declared a quarterly dividend, which was paid on September 9th. Shareholders of record on August 5th received a dividend of $0.5675 per share, with an ex-dividend date also on August 5th. This translates to an annualized dividend of $2.27, yielding 2.8%. The company’s current payout ratio is 38.47%.<\/p>\n (Free Report<\/a>)<\/p>\n MetLife, Inc. is a global financial services company that provides a range of services including insurance, annuities, employee benefits, and asset management. The company operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. Its offerings include life, dental, group short- and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, along with prepaid legal plans and administrative services-only arrangements for employers.<\/p>\n Want to see what other hedge funds are holding MET?<\/strong> Visit HoldingsChannel.com<\/a> for the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET<\/a> \u2013 Free Report<\/a>).<\/p>\n <\/p>\n![\"MetLife](\"https:\/\/www.marketbeat.com\/logos\/metlife-inc-logo-1200x675.png?v=20231227090133\"){kind=logo}
Kathmere Capital Management LLC has significantly increased its stake in MetLife, Inc. (NYSE:MET<\/a> \u2013 Free Report<\/a>), growing its holdings by an impressive 88.2% during the second quarter. According to the latest disclosure with the Securities & Exchange Commission, the firm now owns 6,328 shares of the financial services provider, having purchased an additional 2,965 shares in the quarter. At the end of this reporting period, Kathmere Capital Management LLC’s holdings in MetLife were valued at approximately $509,000.<\/p>\nAnalyst Upgrades and Downgrades<\/h2>\n
MetLife Price Performance<\/h2>\n
MetLife Announces Dividend<\/h2>\n
About MetLife<\/h2>\n
Featured Articles<\/h2>\n
<\/p>\n
\n
\n<\/p>\n